• news.cision.com/
  • Redsense/
  • Redsense Medical announces a strong start of Q4 with incoming order valued over 2 MSEK

Redsense Medical announces a strong start of Q4 with incoming order valued over 2 MSEK

Report this content

Redsense Medical’s commercial momentum and sales are continuing in Q4 and the company already booked a large order of blood leakage alarms and sensors from distribution partner Metro Medical Supply Inc.

Redsense Medical now starts Q4 with an order worth 2 MSEK, compared to a result of 1,8 MSEK for the whole Q4 period the previous year (2018).

“We are very pleased to receive such substantialorder to startQ4. The commercial momentum we have experienced recently has put some positive stress on our supply chain but we are working closely with our suppliers to meet demand. says Patrik Byhmer CEO of Redsense Medical.

For more information, please contact:

Patrik Byhmer, CEO Redsense Medical AB (publ)

Phone: +46 35 10 60 30




Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense System, an innovationused for monitoring and alarm in the case of blood leakage in connection with a hemodialysistreatment. Redsense Medicalsolves one of the most serious remaining safety problems within hemodialysis – to quickly detect Venous Needle Dislodgement and catheter leakage tominimizing blood leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector.


Documents & Links